CBPO [China Biologic Products] 424B5: (Original Filing)
[PROSPECTUS SUPPLEMENT Page About This Prospectus Supplement S-1 Prospectus Supplement Summary S-2 Risk Factors S-8]
CBPO [China Biologic Products] S-3: CALCULATION OF REGISTRATION FEE Title of Each Class
[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered (1) (2) Amount To Be Registered Proposed] [STATE OF DELAWARE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CHINA BIOLOGIC PRODUCTS, INC. Corporation China Biologic Products, Inc., a corporation organized and existing under the laws of the State of Delaware (the “ A. The name of the Corporation is China Biologic Products, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State] [SECOND AMENDED AND RESTATED BYLAWS OF CHINA BIOLOGIC PRODUCTS, INC. (the “Corporation”) Adopted on July 20, 2012 _______________________________________________________ ARTICLE I OFFICES Registered Office Certificate of Incorporation Section 1.01. Other Offices Board of Directors Board Section 1.02. ARTICLE II MEETINGS OF STOCKHOLDERS Annual Meeting Section 2.01. Voting List Section 2.02. Special Meeting Section 2.03. Advance Notice Procedures Section 2.04. Advance Notice] [June 6, 2014 China Biologic Products, Inc. 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China Re: Registration Statement on Form S-3 Ladies and Gentlemen: Registration Statement Company Commission Act At your request, we have examined the Registration Statement on Form S-3 (the “ Prospectus Prospectus Supplement Common Stock Preferred Stock Units] [China Biologic Products, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES Year ended December 31, Three months 2009 2010 2011 2012 2013 2014 Fixed charges: Interest expensed and capitalized $ 4,423,136 $ 1,087,290 $ 1,147,315 $ 1,249,982] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the use of our reports with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and to the reference to our firm under the heading “Experts” in the registration statement. Hong Kong, China June 6, 2014]
CBPO [China Biologic Products] 8-K: (Original Filing)
[Amended and Restated Employment Agreement Agreement Company Executive This Amended and Restated Employment Agreement (this “ Original Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ WHEREAS, the term of the Original Agreement will expire on May 11, 2014; and WHEREAS, the Company and the Executive desire to extend] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 11, 2014 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3166 ____________________________________________________________ (Former name or former]
CBPO [China Biologic Products] 8-K: Amended and Restated Employment Agreement Agreement Company Executive
[Amended and Restated Employment Agreement Agreement Company Executive This Amended and Restated Employment Agreement (this “ Original Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ WHEREAS, the term of the Original Agreement will expire on May 11, 2014; and WHEREAS, the Company and the Executive desire to extend] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 11, 2014 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3166 ____________________________________________________________ (Former name or former]
CBPO [China Biologic Products] 8-K: (Original Filing)
[CHINA BIOLOGIC PRODUCTS, INC. DIRECTOR AGREEMENT Agreement Company Mr. Dai Feng Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy due to resignation of Dr. Bing Li and to have the Director perform the duties of a director and the Director desires to be so appointed] []
